1.Observation on the clinical effiect of Aidi injection and Huaier particles combined with interventional therapy for primary liver cancer
Chengsheng OUYANG ; Zhenjiang YANG ; Honghui GU ; Lina YANG ; Zhong CHEN ; Taoli WANG ; Zonggui XIE
Chinese Journal of Primary Medicine and Pharmacy 2011;18(10):1339-1340
Objective To observe the clinical effiect and toxicity of Aidi injection and Huaier particles combined with interventional therapy for primary liver cancer patients.Methods 43 paients with primary liver cancer were randomly divided into two groups:the treatment group 22 cases(Aidi injection and Huaier particles combined with interventional therapy to the primary liver cancer)and the control group 21 cases(treated only with intervention therapy of liver cancer).The recent efficiency and toxicity of the two groups were compared.Results The effective rate of the treatment group was 59.1%,and in control group was 33.3%,and the differences was significant(P<0.01).In the treatment group,clinical benefit rate was 86.4%higher than than of the control group(71.4%),and the difference was significant(P<0.05);The treatment group significantly improved the quality of life of patients,T cell and NK cell activity were improved,and better than the control group(P<0.05).The incidence of gastrointestinal reactions and neutropenia rate in treatment group was lower than the control group(all P<0.05).Conclusion Aidi injection and Huaier Granule interventional therapy could improve the curative effect of primary liver cancer、the immune activity、quality of patients life,and the adverse effects.